Absence of relationship between serum cortisol and critical illness in premature infants.
Absence of relationship between serum cortisol and critical illness in premature infants.
复制标题
DOI:
10.1136/archdischild-2020-319970
复制
发表时间:
2021-07
期刊:
影响因子:
--
通讯作者:
Bernier A
中科院分区:
文献类型:
--
作者:
Prelipcean I;Wynn JL;Thompson L;Burchfield DJ;James-Woodley L;Chase PB;Barnes CP;Bernier A
Inadequate cortisol production in response to critical illness in extremely preterm infants may exacerbate poor outcomes. Despite commonly measuring cortisol concentration and administering hydrocortisone for presumed adrenal insufficiency, the relationship between serum cortisol concentration and illness severity remains unclear in this unique population. To determine the relationship between cortisol concentrations and illness severity as measured by the Score for Neonatal Acute Physiology (SNAP-II), neonatal Sequential Organ Failure Assessment (nSOFA), and Vasoactive-Inotropic Score (VIS) in premature infants. This retrospective, single-center cohort study included preterm infants born <30 weeks gestational age admitted to a level IV NICU between June 2011 - July 2018, who had a serum cortisol obtained for clinical indications before 36 weeks post-menstrual age. Demographic data were collected on infants and mothers. Nine clinical variables were identified a priori that could potentially modify cortisol concentration including critical illness. Univariate and multivariable analyses determined the relationship between cortisol concentration and each of these variables. A total of 224 preterm infants with pretreatment serum cortisol concentration met criteria for inclusion. The median (IQR) gestational age at birth was 25 weeks (24, 26) and at cortisol measurement was 26 weeks (25, 28). The median cortisol was 13.3 ug/dL. Non-survivors had the highest values. Cortisol concentration did not correlate with any of the selected illness severity scores. Cortisol concentrations in extremely preterm infants did not correlate with illness severity regardless of gestational age. Further studies are needed to identify clinically useful mediators of adrenal dysfunction and to guide clinical management.
登录
查看更多内容
影响因子:
3.6
作者:
Gatelais, F;Berthelot, J;Coutant, R
通讯作者:
Coutant, R
影响因子:
5.8
作者:
Heckmann, M;Hartmann, MF;Wudy, SA
通讯作者:
Wudy, SA
DOI:
10.1136/adc.2002.021972
发表时间:
2004-03-01
影响因子:
4.4
作者:
Ng, PC;Lee, CH;Wong, E
通讯作者:
Wong, E
影响因子:
3.6
作者:
Biswas, S;Buffery, J;Walters, D
通讯作者:
Walters, D
影响因子:
2.9
作者:
Aucott, S. W.;Watterberg, K. L.;Donohue, P. K.
通讯作者:
Donohue, P. K.